Omeros Corporation OMER
13.21 USD -0.80 (-5.71%)
Regular-session close
13.21 0.00 0.00%
After hours · Nov 20, 4:01 PM ET
13.07 Day range 13.88
8.23 52-week range 21.05
- YTD
- -23.11%
- 1 year
- +60.51%
News
seekingalpha.com Omeros: Yartemlea Commercial Momentum Supports Upgrade Despite Q3 Deceleration (Rating Upgrade) Omeros earns a speculative buy upgrade: YARTEMLEA's stronger-than-expected launch supports a valuation floor, while zaltenibart and the pipeline offer upside. Q3 net product revenue rose 26%…
benzinga.com Why Is Omeros Stock Trading Lower Tuesday? Omeros shares slide after mixed Q3 results—Yartemlea sales jump 26% sequentially, but revenue misses and EU setbacks weigh.benzinga.com HC Wainwright & Co. Reiterates Buy on Omeros, Maintains $33 Price Target HC Wainwright & Co. analyst Brandon Folkes reiterates Omeros (NASDAQ:OMER) with a Buy and maintains $33 price target.
benzinga.com Red Cat Downbeat Q3 Results, Joins Omeros, Deutsche Bank And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session U.S. stock futures fell as Red Cat plunged 25.8% after weak Q3 results and withdrawing FY26 guidance; several stocks also declined premarket.
marketbeat.com Omeros Q3 Earnings Call Highlights Omeros NASDAQ: OMER reported higher third-quarter sales of its transplant complication treatment YARTEMLEA and a second consecutive quarter of positive operating cash flow, while a non-cash…
seekingalpha.com Omeros Corporation (OMER) Q3 2026 Earnings Call Transcript Omeros Corporation (OMER) Q3 2026 Earnings Call Transcript
zacks.com Omeros (OMER) Surpasses Q3 Earnings and Revenue Estimates Omeros (OMER) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.05 per share. This compares to a loss of $0.19 per share a year ago.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Dare Bioscience (NASDAQ:DARE) shares rose 9.5% to $0.64 during Monday's after-market session. The company's market cap stands at $12.9 million. As per the press release, Q3 earnings came out…benzinga.com Omeros Q3 Adj. EPS $0.06 Beats $0.03 Estimate, Sales $35.934M Miss $37.267M Estimate Omeros (NASDAQ:OMER) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.03 by 100 percent. This is a 117.65 percent increase over losses of $(0.34) per…
businesswire.com Omeros Corporation Reports Third Quarter 2026 Financial Results SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced recent highlights and developments as well as financial results for the third quarter ended September 30, 2026, which…
